CAJ – Credit Suisse rates the stock as Outperform

By Broker News | More Articles by Broker News

First-half results were in line but Credit Suisse finds more positives have flowed. The broker believes the update, which showed improvement across organic growth and cash flow, serves as a first step in justifying a re-rating process that has some way to go.

The broker assesses this is the best result from the company for some time. Outperform rating maintained. Target rises to $0.34 from $0.32.

Sector: Health Care Equipment & Services.

Target price is $0.34.Current Price is $0.28. Difference: $0.06 – (brackets indicate current price is over target). If CAJ meets the Credit Suisse target it will return approximately 18% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →